Underwriters Laboratories, (UL) has expanded its medical industry services to include Biocompatibility testing. Biocompatibility test reports are part of the regulatory submissions required by the regulatory bodies in the three major medical device markets – United States FDA, Japan MH LW, and European Union Notified Bodies – and support UL's leadership as an end-to-end regulatory and certification services provider for the global medical industry.
Medical and IVD manufacturers can now receive a complete test package through UL's network for all the tests necessary to complete technical file submissions. By working with UL, manufacturers may customize test protocols to minimize testing, samples required and time, while meeting multiple country preferred test methods.
Through its relationships, UL also offers customers access to microbiology, analytical and bioanalytical chemistry, pharmaceutical analysis, and extractable & leachable analysis.
To find out more about UL's biocompatibility and analytical testing services and download your copy of the matrix of requirement for FDA, ISO and MHLW visit: ul.com/hitech/ biocompatibility.
Explore the August 2008 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Best of 2024: #9 Article – Strategy Milling combines old and new for precision dental restorations
- Best of 2024: #9 News – Global robotics race
- Best of 2024: #10 Article – Designing medical devices for every user
- Best of 2024: #10 News – 4 predictions for 2024: AI set to supercharge robotic automation
- Children’s National, FDA collaborate to advance pediatric device regulatory tools
- LK Metrology’s eco-friendliness CMMs
- Two patents for microfluidic valves
- AMADA WELD TECH’s blue diode laser technology